Body composition changes and predictors of lipodystrophy in a cohort of pre-pubertal HIV-infected children.

1 Division of Nutrology, Departament of Pediatrics, Escola Paulista de Medicina, Universidade Federal de Sao Paulo (UNIFESP/EPM), 04040-032, Sao Paulo, SP, Brazil. Division of Pediatric Infectious Diseases, Departament of Pediatrics, Escola Paulista de Medicina, Universidade Federal de Sao Paulo (UNIFESP/EPM), 04040-003 Sao Paulo, SP, Brazil. Division of Rheumatology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de Sao Paulo (UNIFESP/EPM), 04023-900, Sao Paulo, Brazil.

[1]  R. Haubrich,et al.  Biceps Skin-fold Thickness May Detect and Predict Early Lipoatrophy in HIV-infected Children , 2013, The Pediatric infectious disease journal.

[2]  C. Palchetti,et al.  Body composition and lipodystrophy in prepubertal HIV-infected children , 2013, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[3]  G. McComsey,et al.  Metabolic complications and treatment of perinatally HIV-infected children and adolescents , 2013, Journal of the International AIDS Society.

[4]  L. Kuhn,et al.  Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy , 2012, Archives of Disease in Childhood.

[5]  R. A. Rascón-Pacheco,et al.  Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents. , 2012, European journal of endocrinology.

[6]  W. Borkowsky,et al.  Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study. , 2011, The American journal of clinical nutrition.

[7]  Ò. Miró,et al.  Mitochondrial Impact of Human Immunodeficiency Virus and Antiretrovirals on Infected Pediatric Patients With or Without Lipodystrophy , 2011, The Pediatric infectious disease journal.

[8]  W. Borkowsky,et al.  Factors Associated with Insulin Resistance among Children and Adolescents Perinatally Infected with HIV-1 in the Pediatric HIV/AIDS Cohort Study , 2011, Hormone Research in Paediatrics.

[9]  M. Muñoz-Fernández,et al.  Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome. , 2011, The Journal of infection.

[10]  M. Theodoridou,et al.  Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy , 2011, Hormones.

[11]  A. Fernandes,et al.  Lipodystrophy, lipid profile changes, and low serum retinol and carotenoid levels in children and adolescents with acquired immunodeficiency syndrome. , 2010, Nutrition.

[12]  T. Miller.  The next decade: cardiovascular risks, outcomes, prevention, and treatment in pediatric HIV infection. , 2010, Jornal de pediatria.

[13]  Marcos V. Pone,et al.  Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy. , 2010, Jornal de pediatria.

[14]  R. Shafer.  The challenge of antiretroviral drug resistance in HIV-1-infected children. , 2009, Jornal de pediatria.

[15]  R. Parker,et al.  The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications , 2009, Toxicologic pathology.

[16]  Jens C. Krause,et al.  Metabolic Abnormalities in Human Immunodeficiency Virus-Infected Children: Two-Year Follow-up , 2009, Journal of pediatric endocrinology & metabolism : JPEM.

[17]  A. Franzese,et al.  Is resistin a link between highly active antiretroviral therapy and fat redistribution in HIV-infected children? , 2008, Journal of endocrinological investigation.

[18]  M. Sormani,et al.  Evaluation of insulin resistance in a cohort of HIV-infected youth. , 2007, European journal of endocrinology.

[19]  R. Rutstein,et al.  Hypoadiponectinemia, Dyslipidemia, and Impaired Growth in Children with HIV-associated Facial Lipoatrophy , 2007, Journal of pediatric endocrinology & metabolism : JPEM.

[20]  M. J. García-Miguel,et al.  Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children , 2005, European Journal of Pediatrics.

[21]  P. Brambilla,et al.  Increased Lipodystrophy Is Associated With Increased Exposure to Highly Active Antiretroviral Therapy in HIV-Infected Children , 2003, Journal of acquired immune deficiency syndromes.

[22]  P. Brambilla,et al.  Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy , 2001, AIDS.

[23]  M. Polak,et al.  Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children , 2000, AIDS.

[24]  D. Cooper,et al.  Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance , 1998, The Lancet.

[25]  C. Bloch,et al.  Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. , 1995, The Journal of clinical endocrinology and metabolism.

[26]  W. A. Marshall,et al.  Growth and physiological development during adolescence. , 1968, Annual review of medicine.